Multi-modular Chimeric Antigen Receptor Targeting GD2 in Neuroblastoma
Condition: Neuroblastoma Intervention: Biological: GD2 CAR T cells Sponsor: University College, London Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials